论文部分内容阅读
目的:探讨阿奇霉素治疗支原体肺炎患者的临床效果。方法:将2014年1月至2015年1月在我院接受治疗的46例支原体肺炎患者,随机分为观察组23例(采用阿奇霉素治疗)和对照组23例(采用红霉素治疗),对比两组患者的临床治疗效果。结果:观察组的总有效率达到了95.65%(22/23),显著高于对照组的78.26%(18/23),两组相比差异具有统计学意义(P<0.05)。结论:针对支原体肺炎患者采用阿奇霉素治疗的效果显著,能够有效改善患者生命质量,值得临床推广应用。
Objective: To investigate the clinical effect of azithromycin in patients with mycoplasma pneumonia. Methods: Forty-six patients with mycoplasma pneumonia who were treated in our hospital from January 2014 to January 2015 were randomly divided into observation group of 23 cases (treated with azithromycin) and control group of 23 cases (treated with erythromycin), and compared Clinical efficacy of two groups of patients. Results: The total effective rate of the observation group reached 95.65% (22/23), which was significantly higher than that of the control group (78.26%, 18/23). The difference between the two groups was statistically significant (P <0.05). Conclusion: The treatment of mycoplasma pneumonia patients with azithromycin significant effect, can effectively improve the quality of life of patients, it is worth promoting the clinical application.